JP Morgan Chase’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.9M Buy
74,300
+26,600
+56% +$9.48M ﹤0.01% 1868
2025
Q4
$15.6M Buy
47,700
+22,000
+86% +$6.98M ﹤0.01% 2278
2025
Q3
$7.25M Sell
25,700
-33,500
-57% -$9.72M ﹤0.01% 3014
2025
Q2
$16.5M Sell
59,200
-201,300
-77% -$57M ﹤0.01% 2101
2025
Q1
$81.2M Buy
260,500
+122,800
+89% +$36.3M 0.01% 1044
2024
Q4
$35.9M Buy
137,700
+1,500
+1% +$445K ﹤0.01% 1532
2024
Q3
$43.9M Sell
136,200
-6,900
-5% -$2.26M ﹤0.01% 1408
2024
Q2
$44.7M Sell
143,100
-121,500
-46% -$35.7M ﹤0.01% 1310
2024
Q1
$75.2M Buy
264,600
+150,200
+131% +$43.9M 0.01% 1081
2023
Q4
$32.9M Buy
114,400
+31,300
+38% +$8.53M ﹤0.01% 1471
2023
Q3
$22.3M Buy
83,100
+37,400
+82% +$9.33M ﹤0.01% 1595
2023
Q2
$10.1M Sell
45,700
-35,700
-44% -$8.28M ﹤0.01% 2274
2023
Q1
$19.7M Buy
81,400
+70,800
+668% +$17.4M ﹤0.01% 1670
2022
Q4
$2.78M Sell
10,600
-28,700
-73% -$7.69M ﹤0.01% 3309
2022
Q3
$8.86M Buy
39,300
+17,600
+81% +$4.27M ﹤0.01% 2250
2022
Q2
$5.28M Buy
21,700
+2,100
+11% +$515K ﹤0.01% 2748
2022
Q1
$4.74M Sell
19,600
-18,300
-48% -$4.2M ﹤0.01% 3052
2021
Q4
$8.53M Hold
37,900
﹤0.01% 2596
2021
Q3
$8.06M Sell
37,900
-24,500
-39% -$5.64M ﹤0.01% 2593
2021
Q2
$15.2M Buy
62,400
+23,600
+61% +$5.81M ﹤0.01% 2068
2021
Q1
$9.65M Sell
38,800
-18,700
-33% -$4.46M ﹤0.01% 2394
2020
Q4
$13.2M Sell
57,500
-62,000
-52% -$14.3M ﹤0.01% 1970
2020
Q3
$29.7M Buy
119,500
+43,200
+57% +$10.7M 0.01% 1243
2020
Q2
$18M Buy
76,300
+46,600
+157% +$10.6M ﹤0.01% 1439
2020
Q1
$6.02M Sell
29,700
-112,200
-79% -$24.5M ﹤0.01% 2113
2019
Q4
$34.2M Sell
141,900
-4,300
-3% -$948K 0.01% 1187
2019
Q3
$28.3M Sell
146,200
-3,600
-2% -$691K 0.01% 1331
2019
Q2
$27.6M Buy
149,800
+86,800
+138% +$15.5M 0.01% 1334
2019
Q1
$12M Sell
63,000
-13,300
-17% -$2.54M ﹤0.01% 1896
2018
Q4
$14.9M Buy
76,300
+2,000
+3% +$390K ﹤0.01% 1710
2018
Q3
$15.4M Sell
74,300
-32,500
-30% -$6.4M ﹤0.01% 1858
2018
Q2
$19.7M Buy
106,800
+2,200
+2% +$389K ﹤0.01% 1594
2018
Q1
$17.8M Buy
104,600
+8,900
+9% +$1.63M ﹤0.01% 1587
2017
Q4
$16.6M Sell
95,700
-80,000
-46% -$14.2M ﹤0.01% 1715
2017
Q3
$32.6M Buy
175,700
+73,800
+72% +$13.1M 0.01% 1185
2017
Q2
$17.6M Sell
101,900
-54,732
-35% -$8.9M ﹤0.01% 1549
2017
Q1
$25.7M Sell
156,632
-13,068
-8% -$2.17M 0.01% 1306
2016
Q4
$24.8M Sell
169,700
-79
-0% -$11.9K 0.01% 1321
2016
Q3
$28.3M Sell
169,779
-16,400
-9% -$2.77M 0.01% 1153
2016
Q2
$28.3M Buy
186,179
+19,740
+12% +$3.07M 0.01% 1158
2016
Q1
$25M Sell
166,439
-258,661
-61% -$38.4M 0.01% 1197
2015
Q4
$69M Sell
425,100
-258,500
-38% -$40.6M 0.02% 679
2015
Q3
$94.6M Buy
683,600
+16,219
+2% +$2.56M 0.03% 560
2015
Q2
$102M Sell
667,381
-45,319
-6% -$7.26M 0.02% 592
2015
Q1
$114M Buy
712,700
+30,400
+4% +$4.79M 0.03% 587
2014
Q4
$109M Buy
682,300
+348,300
+104% +$54.3M 0.02% 606
2014
Q3
$46.9M Buy
+334,000
New +$43.6M 0.01% 926
2014
Q1
Sell
-37,500
Closed -$4.28M 3569
2013
Q4
$4.28M Sell
37,500
-38,100
-50% -$4.33M ﹤0.01% 2268
2013
Q3
$8.46M Hold
75,600
﹤0.01% 1859
2013
Q2
$7.46M Buy
+75,600
New +$7.85M ﹤0.01% 1861

Other funds holding AMGN

JP Morgan Chase's AMGN Position: Q1 2026 in Review

JP Morgan Chase increased its Amgen (AMGN) stake by 217% in Q1 2026, buying an estimated $1.78B and bringing the position to 7,277,837 shares worth $2.54B. The position accounts for 0.16% of the portfolio, ranked #136.

JP Morgan Chase first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • JP Morgan Chase held 7,277,837 shares of Amgen worth $2.54B as of Q1 2026.
  • JP Morgan Chase bought 4,984,212 Amgen shares in Q1 2026, an estimated $1.78B.
  • Amgen made up 0.16% of JP Morgan Chase's portfolio in Q1 2026, its #136 holding.
  • JP Morgan Chase first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.